SARS-CoV-2 (COVID-19) Coronavirus, Molecular
SARS-CoV-2 is the seventh known coronavirus causing respiratory infection in humans, after 229E, NL63, OC43, HKU1, MERS-CoV, and the original SARS-CoV. Based on its genome sequence, SARS-CoV-2 is a positive-sense, single-stranded RNA coronavirus (+ssRNA) belongs to the 2B group of the betacoronavirus family, which is the same family as SARS-CoV and MERS-CoV and has 70% similarity in genetic sequence to SARS. Each SARS-CoV-2 virion is approximately 50–200 nanometers in diameter and composed of several proteins including the spike (S), envelope (E), membrane (M), and nucleocapsid (N); the N protein holds the RNA genome, and the S, E, and M proteins together create the viral envelope. Its spike protein has sufficient affinity to the angiotensin-converting enzyme 2 (ACE2) receptor to use it as a mechanism of cell entry.
SARS-CoV-2 is the causative agent of coronavirus disease 2019 (COVID-19). The World Health Organization (WHO) declared the 2019–20 coronavirus outbreaks a Public Health Emergency of International Concern (PHEIC) on 30 January 2020 and a pandemic on 11 March 2020. Symptoms of COVID-19 range from mild fever, cough, and shortness of breath, muscle pain, diarrhea, and sore throat to pneumonia and multi-organ failure. The disease is transmitted from human-to-human by close contact, via respiratory droplets generated by sneezing and coughing. It may also spread when one touches a contaminated surface and then their face. The incubation period appears to be 2-14 days. The laboratory testing for the COVID-19 and the associated SARS-CoV-2 virus includes methods that detect the presence of the viral nucleic acids, rapid tests to detect viral antigens and those that detect antibodies produced in response to infection. Detection of the viral RNA by molecular method such as reverse transcriptase polymerase chain reaction (RT-PCR) is preferable and widely adopted test in COVID-19 testing, especially for early detection and infection spreading management.
- Diagnosis of acute respiratory distress syndrome and sever pneumonia caused by SARS-CoV-2 coronavirus
- Useful for epidemiological surveillance and management
If positive indicates COVID-19 infection often causing acute respiratory distress syndrome and/or sever pneumonia.
Recommendation for testing:
- For early (onset) detection use Molecular (Swab): Alternatively Antigen test can be used, but all negative test must be retested by Molecular
- For immunity evaluation use Antibody IgG assay only
- No value or recommendation for use of IgM or IgA
Not Detected (Negative)
Nasopharyngeal swab, Oropharyngeal swab collected in Universal Transport Media (UTM) or Universal Viral Transport Media or UVT, Sputum.
Stability
- Ambient: 1-3 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Int J Occup Environ Med. 2020 Feb 5;11(2):65-71. [PMID: 32020915]
- Lancet Infect Dis. 2020 Mar 23. pii: S1473-3099(20)30196-1. [PMID: 32213337]
- Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917. [PMID: 31992387]
- Int J Antimicrob Agents. 2020 Feb 17:105924. [PMID: 32081636]
- J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25709. [PMID: 32056249]
- Clin Chem. 2020 Jan 31:hvaa029. [PMID: 32031583]
- Clin Chem Lab Med. 2020 Mar 3. doi: 10.1515/cclm-2020-0198. [PMID: 32119647]
- One Health. 2020 Jun; 9: 100124. Published online 2020 Feb 24. [PMID: 32195311]